95.41
前日終値:
$97.28
開ける:
$97.3
24時間の取引高:
8.05M
Relative Volume:
0.97
時価総額:
$141.37B
収益:
$18.49B
当期純損益:
$2.50B
株価収益率:
56.79
EPS:
1.6801
ネットキャッシュフロー:
$3.49B
1週間 パフォーマンス:
-1.96%
1か月 パフォーマンス:
-9.33%
6か月 パフォーマンス:
+2.99%
1年 パフォーマンス:
+10.68%
Boston Scientific Corp Stock (BSX) Company Profile
名前
Boston Scientific Corp
セクター
電話
508-683-4000
住所
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-10-03 | ダウングレード | Erste Group | Buy → Hold |
2025-09-08 | アップグレード | Oppenheimer | Perform → Outperform |
2025-06-16 | 開始されました | Leerink Partners | Outperform |
2025-04-16 | アップグレード | Needham | Hold → Buy |
2025-01-10 | アップグレード | Deutsche Bank | Hold → Buy |
2024-10-18 | ダウングレード | Needham | Buy → Hold |
2024-05-30 | 開始されました | Goldman | Buy |
2024-02-01 | アップグレード | Mizuho | Neutral → Buy |
2023-07-19 | 開始されました | Robert W. Baird | Outperform |
2023-06-30 | 開始されました | CL King | Buy |
2023-05-30 | 再開されました | Morgan Stanley | Overweight |
2023-03-29 | 開始されました | UBS | Buy |
2022-12-22 | 開始されました | Mizuho | Neutral |
2022-12-20 | 再開されました | Citigroup | Buy |
2022-10-18 | 開始されました | Barclays | Overweight |
2022-10-12 | 開始されました | Jefferies | Buy |
2022-07-06 | 開始されました | Wolfe Research | Outperform |
2022-05-27 | アップグレード | Needham | Hold → Buy |
2022-04-13 | 再開されました | Truist | Buy |
2022-03-02 | 再開されました | BofA Securities | Buy |
2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
2021-05-26 | ダウングレード | Needham | Buy → Hold |
2021-05-25 | 開始されました | Barclays | Overweight |
2021-04-15 | 開始されました | Atlantic Equities | Overweight |
2020-09-17 | 開始されました | Truist | Buy |
2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
2020-04-22 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
2020-04-01 | アップグレード | Goldman | Neutral → Buy |
2020-03-05 | 開始されました | Citigroup | Buy |
2020-02-13 | 開始されました | Goldman | Neutral |
2020-02-06 | 再開されました | BTIG Research | Buy |
2019-12-30 | 繰り返されました | Cowen | Outperform |
2019-12-19 | ダウングレード | Needham | Strong Buy → Buy |
2019-09-05 | 再開されました | JP Morgan | Overweight |
2019-09-03 | 再開されました | Barclays | Overweight |
2019-05-13 | アップグレード | Evercore ISI | In-line → Outperform |
2018-11-28 | 開始されました | UBS | Buy |
2018-10-16 | 開始されました | Barclays | Overweight |
2018-10-02 | 繰り返されました | Morgan Stanley | Overweight |
2018-09-07 | 繰り返されました | Needham | Strong Buy |
2018-09-04 | アップグレード | Jefferies | Hold → Buy |
2018-07-06 | 繰り返されました | Needham | Strong Buy |
2018-06-27 | 開始されました | Bernstein | Outperform |
2018-04-26 | 繰り返されました | Needham | Strong Buy |
すべてを表示
Boston Scientific Corp (BSX) 最新ニュース
Aberdeen Group plc Trims Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific stock rating reiterated at Buy by TD Cowen - Investing.com
Is Boston Scientific Corporation stock a safe buy pre earningsQuarterly Earnings Report & Low Risk High Reward Trade Ideas - newser.com
November 28th Options Now Available For Boston Scientific (BSX) - Nasdaq
Real time alert setup for Boston Scientific Corporation performance2025 Market WrapUp & AI Based Buy and Sell Signals - newser.com
How to forecast Boston Scientific Corporation trends using time series2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Boston Scientific: Not In The Most Resolute State As It Approaches Q3 Earnings - Seeking Alpha
Boston Scientific’s SWOT analysis: medtech giant’s stock poised for growth - Investing.com
Shell Asset Management Co. Increases Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corp. Experiences Evaluation Revision Amidst Market Dynamics and Performance Variability - Markets Mojo
Evercore ISI Revises Boston Scientific (BSX) Price Target to $11 - GuruFocus
Boston Scientific (BSX) Target Price Cut by Evercore ISI Amid Ma - GuruFocus
Boston Scientific (BSX): Evaluating Valuation as Analyst Confidence Remains High Following Strong Segment Growth and Innovation - simplywall.st
What You Need To Know Ahead Of Boston Scientific's Earnings Release - Barchart.com
Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term - Yahoo Finance
Using data tools to time your Boston Scientific Corporation exitMarket Trend Report & Weekly Stock Breakout Alerts - newser.com
Cullinan Associates Inc. Sells 13,300 Shares of Boston Scientific Corporation $BSX - MarketBeat
Knights of Columbus Asset Advisors LLC Purchases 5,188 Shares of Boston Scientific Corporation $BSX - MarketBeat
A Quick Look at Today's Ratings for Boston Scientific(BSX.US), With a Forecast Between $125 to $136 - 富途牛牛
QRG Capital Management Inc. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Why Boston Scientific Corporation stock remains on watchlists2025 Geopolitical Influence & Low Risk Entry Point Tips - newser.com
Is Boston Scientific’s Innovation Push in Endoscopy at MEDevice Boston a Sign of R&D Leadership (BSX)? - Yahoo Finance
Penobscot Investment Management Company Inc. Buys 10,177 Shares of Boston Scientific Corporation $BSX - MarketBeat
Jackson Wealth Management LLC Has $4.91 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Empirical Financial Services LLC d.b.a. Empirical Wealth Management Raises Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Mirae Asset Global Investments Co. Ltd. Grows Position in Boston Scientific Corporation $BSX - MarketBeat
Truist Financial Corp Sells 18,116 Shares of Boston Scientific Corporation $BSX - MarketBeat
How Are Analysts Weighing Boston Scientific’s (BSX) Innovation Pipeline Against Market Execution Strategies? - simplywall.st
Down 10.3% in 4 Weeks, Here's Why You Should You Buy the Dip in Boston Scientific (BSX) - Yahoo Finance
Boston Scientific stock rating reiterated at Overweight by Piper Sandler - Investing.com
FY2027 EPS Estimate for Boston Scientific Boosted by Analyst - MarketBeat
The Zacks Analyst Blog Highlights Boston Scientific, Union Pacific, Realty Income and Weyco - sharewise.com
Boston Scientific stock rating downgraded to Hold by Erste Group - Investing.com
RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT - Insider Monkey
Consolidated Portfolio Review Corp Acquires Shares of 3,136 Boston Scientific Corporation $BSX - MarketBeat
How Boston Scientific Corporation stock benefits from digital adoptionEarnings Risk Report & Detailed Earnings Play Alerts - newser.com
Top Research Reports for Boston Scientific, Union Pacific & Realty Income - Yahoo Finance
Oppenheimer Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
Leerink Partners Reaffirms Their Buy Rating on Boston Scientific (BSX) - The Globe and Mail
Truist Financial Sticks to Their Buy Rating for Boston Scientific (BSX) - The Globe and Mail
27,070 Shares in Boston Scientific Corporation $BSX Bought by Lecap Asset Management Ltd. - MarketBeat
Boston Scientific aims for market leadership in electrophysiology - Yahoo Finance
Boston Scientific (NYSE:BSX) Receives “Buy” Rating from Needham & Company LLC - Defense World
Boston Scientific (NYSE:BSX) Price Target Raised to $129.00 at Truist Financial - Defense World
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Boston Sci closes Elutia deal, projects 10% growth through 2028 - BioWorld MedTech
Oppenheimer reiterates Outperform rating on Boston Scientific stock By Investing.com - Investing.com Nigeria
Boston Scientific (BSX) Analyst Rating Update: Canaccord Genuity Raises Price Target | BSX Stock News - GuruFocus
Elutia Announces Closing Of Bioenvelope Business Sale To Boston Scientific Corporation - TradingView
What consensus target says about Boston Scientific Corporation stock2025 Biggest Moves & Verified Entry Point Detection - newser.com
Baird Raises Price Target for Boston Scientific (BSX) to $128.00 | BSX Stock News - GuruFocus
Boston Scientific Corp (BSX) 財務データ
収益
当期純利益
現金流量
EPS
Boston Scientific Corp (BSX) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Oct 01 '25 |
Sale |
98.47 |
50,000 |
4,923,327 |
178,342 |
大文字化:
|
ボリューム (24 時間):